| __timestamp | Intra-Cellular Therapies, Inc. | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 10337679 | 91733000 |
| Thursday, January 1, 2015 | 18187286 | 87644000 |
| Friday, January 1, 2016 | 24758063 | 92365000 |
| Sunday, January 1, 2017 | 23666957 | 85656000 |
| Monday, January 1, 2018 | 30099855 | 88196000 |
| Tuesday, January 1, 2019 | 64947625 | 89971000 |
| Wednesday, January 1, 2020 | 186363444 | 93413000 |
| Friday, January 1, 2021 | 272611040 | 91355000 |
| Saturday, January 1, 2022 | 358782000 | 113676000 |
| Sunday, January 1, 2023 | 409864000 | 198366000 |
| Monday, January 1, 2024 | 218935000 |
Data in motion
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. This chart compares the SG&A expenses of Intra-Cellular Therapies, Inc. and Taro Pharmaceutical Industries Ltd. from 2014 to 2023.
Intra-Cellular Therapies, Inc. has seen a dramatic increase in SG&A expenses, rising nearly 40 times from 2014 to 2023. This surge reflects the company's aggressive expansion and investment in marketing and administrative capabilities. In contrast, Taro Pharmaceutical Industries Ltd. has maintained a more stable SG&A expense profile, with a modest increase of about 115% over the same period.
The data highlights the contrasting strategies of these two companies: one focusing on rapid growth and the other on steady, controlled expansion. Missing data for 2024 suggests that the trend for Intra-Cellular Therapies, Inc. is yet to be determined.
Who Optimizes SG&A Costs Better? Gilead Sciences, Inc. or Intra-Cellular Therapies, Inc.
Operational Costs Compared: SG&A Analysis of GSK plc and Intra-Cellular Therapies, Inc.
Intra-Cellular Therapies, Inc. vs Summit Therapeutics Inc.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Intra-Cellular Therapies, Inc. and Bio-Techne Corporation
Cost Management Insights: SG&A Expenses for Intra-Cellular Therapies, Inc. and Ascendis Pharma A/S
Intra-Cellular Therapies, Inc. and TG Therapeutics, Inc.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Intra-Cellular Therapies, Inc. vs Verona Pharma plc
Intra-Cellular Therapies, Inc. vs ADMA Biologics, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Intra-Cellular Therapies, Inc. vs Geron Corporation Trends and Insights
Operational Costs Compared: SG&A Analysis of Dr. Reddy's Laboratories Limited and Taro Pharmaceutical Industries Ltd.
Blueprint Medicines Corporation vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends
Comparing SG&A Expenses: Veracyte, Inc. vs Taro Pharmaceutical Industries Ltd. Trends and Insights